Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001415889-22-008769 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-17 | 2022-08-15 | CLDX | Marucci Anthony S | Pres, CEO, Dir | S - Sale+OE | $37.66 | -120.0K | 27.7K | -81% | -$4.52M |
| DM | 2022-08-17 | 2022-08-15 | CLDX | Marucci Anthony S | Pres, CEO, Dir | M - OptEx | $5.12 | +120.0K | 147.7K | +433% | +$614.4K |
| DM | 2022-08-17 | 2022-08-15 | CLDX | Marucci Anthony S | Pres, CEO, Dir | M - OptEx | $0.00 | -120.0K | 25.0K | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | S | D | 120,000 | $37.66 | 27,692 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.39 to $37.95 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 2 | Common | Common Stock | 2022-08-15 | M | A | 75,000 | $2.78 | 102,692 | D | — | — | (F1) Includes 461 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2022-08-15 | M | A | 45,000 | $9.02 | 147,692 | D | — | — | (F2) This option was previously reported as covering 1,075,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the reverse stock split that occurred on February 8, 2019. |
| 4 | Derivative | Incentive Stock Option | 2022-08-15 | M | D | 45,000 | $0.00 | 26,665 | D | $9.02 · — to 2028-06-13 | 45,000 Common Stock | (F2) This option was previously reported as covering 1,075,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the reverse stock split that occurred on February 8, 2019. (F5) As of June 13, 2022, the option is fully vested. |
| 5 | Derivative | Incentive Stock Option | 2022-08-15 | M | D | 75,000 | $0.00 | 25,000 | D | $2.78 · — to 2029-06-19 | 75,000 Common Stock | (F4) 25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. |